硫酸阿米卡星结构式
|
常用名 | 硫酸阿米卡星 | 英文名 | Amikacin sulfate |
---|---|---|---|---|
CAS号 | 39831-55-5 | 分子量 | 781.760 | |
密度 | N/A | 沸点 | 981.8ºC at 760 mmHg | |
分子式 | C22H47N5O21S2 | 熔点 | 220-230ºC | |
MSDS | 中文版 美版 | 闪点 | N/A |
硫酸阿米卡星用途Amikacin硫酸盐(BAY416651)是半合成氨基葡萄糖苷抗生素,卡那霉素A衍生物。 |
中文名 | 硫酸丁胺卡那霉素 |
---|---|
英文名 | amikacin disulfate |
中文别名 | 硫酸阿米卡星 | 硫酸阿米卡星 | O-3-氨基-3-脱氧-alpha-D-葡吡喃糖基-(1→6)-O-[(6-氨基-6-脱氧-alpha-D-葡吡喃糖基-(1→4)]-N-(4-氨基-2-羟基-1-氧丁基)-2-脱氧-D-链霉胺硫酸盐 | 地佐环平 |
英文别名 | 更多 |
沸点 | 981.8ºC at 760 mmHg |
---|---|
熔点 | 220-230ºC |
分子式 | C22H47N5O21S2 |
分子量 | 781.760 |
精确质量 | 781.220520 |
PSA | 497.90000 |
外观性状 | 固体 |
储存条件 | 密封、阴凉、干燥保存 |
稳定性 | 常规情况下不会分解,没有危险反应 |
水溶解性 | H2O: 50 mg/mL, clear, colorless |
更多 | 1. 性状:粉末 2. 密度(g/mL,25 ºC):未确定 3. 相对蒸汽密度(g/mL,空气=1): 未确定 4. 熔点(ºC):220-230 5. 沸点(ºC):未确定 6. 沸点(ºC,12mm hg):未确定 7. 折射率:未确定 8. 闪点(ºC):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC): 未确定 11. 蒸气压(kPa,25ºC):未确定 12. 饱和蒸气压(kPa,60ºC): 未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:可溶解的 |
硫酸阿米卡星上游产品 0 | |
---|---|
硫酸阿米卡星下游产品 1 | |
Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents.
Antimicrob. Agents Chemother. 58(11) , 6828-36, (2014) Twenty-three 3-nitrotriazole-based and 2-nitroimidazole-based amides and sulfonamides were screened for antitubercular (anti-TB) activity in aerobic Mycobacterium tuberculosis H37Rv by using the BacTi... |
|
Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.
J. Pharm. Biomed. Anal. 102 , 9-16, (2014) A simple and accurate liquid chromatography (LC)-tandem mass spectrometry (MS/MS) method for the quantitation of 20 anti-tuberculosis (anti-TB) drugs in human plasma, was developed as a tool for thera... |
|
Interactions of amikacin with the RNA model of the ribosomal A-site: computational, spectroscopic and calorimetric studies.
Biochimie 102 , 188-202, (2014) Amikacin is a 2-deoxystreptamine aminoglycoside antibiotic possessing a unique l-HABA (l-(-)-γ-amino-α-hydroxybutyric acid) group and applied in the treatment of hospital-acquired infections. Amikacin... |
2-[(3-aminopropyl)amino]ethylphosphorothioic acid monohydrate |
Amifostina |
Amifostinum |
Amikacin disulfate salt |
EINECS 254-648-6 |
D-Streptamine |
amikacin disulphate |
Amikacin Sulphate |
MFCD00167475 |
amifostine monohydrate |
Butanamide, 4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-α-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-β-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl]-2-hydroxy-, (2S)-, sulfate (1:2) (sa lt) |
Amifostine hydrate |
amikacin disulfate |
Butanamide, 4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-α-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl]-2-hydroxy-, (2S)-, sulfate (1:2) (s alt) |
(2S)-4-Amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-α-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-β-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide sulfate (1:2) |
(2S)-4-Amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-α-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide sulfate (1:2) |
Amikacin sulfate |
Amikacin (sulfate) |